Company Clearmind Medicine Inc. Canadian Securities Exchange
Equities
CYN
CA1850534027
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -13.51% | -58.01% |
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,310,616 | 3,310,616 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Clearmind Medicine, Inc.
1220 West 6th Avenue Suite 101
V6H 1A5, Vancouver
+604 260 1566
http://www.clearmindmedicine.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.65% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- CMND Stock
- CYN Stock
- Company Clearmind Medicine Inc.